Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015326
Filing Date
2019-05-02
Accepted
2019-05-02 16:06:25
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20190331.htm 10-Q 1750134
2 EX-10.18 gern-ex1018_162.htm EX-10.18 449434
3 EX-31.1 gern-ex311_10.htm EX-31.1 17409
4 EX-31.2 gern-ex312_6.htm EX-31.2 17427
5 EX-32.1 gern-ex321_8.htm EX-32.1 7635
6 EX-32.2 gern-ex322_11.htm EX-32.2 7622
7 GRAPHIC gpxyxzzinhhz000001.jpg GRAPHIC 4226
8 GRAPHIC gpxyxzzinhhz000002.jpg GRAPHIC 10760
  Complete submission text file 0001564590-19-015326.txt   6082908

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT gern-20190331.xml EX-101.INS 1313704
10 XBRL TAXONOMY EXTENSION SCHEMA gern-20190331.xsd EX-101.SCH 29254
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20190331_cal.xml EX-101.CAL 40969
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20190331_def.xml EX-101.DEF 94930
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20190331_lab.xml EX-101.LAB 263936
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20190331_pre.xml EX-101.PRE 183570
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 19791900
SIC: 2834 Pharmaceutical Preparations